Company / Income Tax per Share
Kiniksa Pharmaceuticals International, plc Income Tax per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax per Share
$0.42
FY2025
5-year range
-$2.79 / $0.42
FY2021-FY2025
Trend
+315.3%
vs FY2024
Sector context
#33 of 201
Health Care
What the data says
Income Tax per Share changed +315% YoY in FY2025, a notable deviation from the 8-year average annual change of -968%.
Based on SEC 10-K filings.
0.42 in FY2025 with a 5-year CAGR of +37.9%. Top quartile in the Health Care sector.
Increased from $-0.45 to $0.42 over the past 2 years.
Health Care sector context is included.
Income Tax per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +37.9%
- 10-Year CAGR
- -
Sector benchmark
Bottom 16% in Health CareTop 84% of 201This company $0.42 Sector average $1.35
▼
-69.2% below sector average
Key checks
Key Insights
- Kiniksa Pharmaceuticals International, plc's income tax per share has grown for 3 consecutive years.
- In FY2025, income tax per share increased 315.3% year-over-year.
- Ranks #33 out of 201 companies in the Health Care sector.
- Lowest income tax per share in the period was in FY2022.
Company context
Key Data Points
- Negative profit margin: -10.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income Tax per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.42 | +315.3% |
| FY2024 | $0.10 | +122.3% |
| FY2023 | -$0.45 | +83.9% |
| FY2022 | -$2.79 | -7258.1% |
| FY2021 | -$0.04 | -145.5% |
| FY2020 | $0.08 | +320.0% |
| FY2019 | -$0.04 | -422.9% |
| FY2018 | -$0.01 | -755.4% |
| FY2017 | $0.00 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026